Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion

被引:44
作者
Wu, Xiaofeng
Fan, Jia [1 ]
Wang, Xiaoying
Zhou, Jian
Qiu, Shuangjian
Yu, Yao
Liu, Yinkun
Tang, Zhaoyou
机构
[1] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China
[3] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
CCR1; hepatocellular carcinoma; neoplasm invasiveness; microRNAs; RNA interference;
D O I
10.1016/j.bbrc.2007.01.199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CC chemokine receptor 1 (CCR1) has an important role in the recruitment of leukocytes to the site of inflammation. The migration and metastasis of tumor cells shares many similarities with leukocyte trafficking, which is mainly regulated by chemokine receptor-ligand interactions. CCR1 is highly expressed in hepatocellular carcinoma (HCC) cells and tissues with unknown functions. In this study, we silenced CCR1 expression in the human HCC cell line HCCLM3 using artificial microRNA (miRNA)-mediated RNA interference (RNAi) and examined the invasiveness and proliferation of CCR1-silenced HCCLM3 cells and the matrix metalloprotemase (MMP) activity. The miRNA-mediated knockdown expression of CCR1 significantly inhibited the invasive ability of HCCLM3 cells, but had only a minor effect on the cellular proliferation rate. Moreover, CCR1 knockdown significantly reduced the secretion of MMP-2. Together, these findings indicate that CCR1 has an important role in HCCLM3 invasion and that CCR1 might be a new target of HCC treatment. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:866 / 871
页数:6
相关论文
共 32 条
[1]  
Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x
[2]   MicroRNAs directing siRNA biogenesis [J].
Bartel, B .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (07) :569-571
[3]  
Begum NA, 1999, INT J ONCOL, V14, P927
[4]   Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study [J].
Davila, JA ;
Morgan, RO ;
Shaib, Y ;
McGlynn, KA ;
El-Serag, HB .
GASTROENTEROLOGY, 2004, 127 (05) :1372-1380
[5]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[6]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[7]   Hepatocellular carcinoma pathogenesis: from genes to environment [J].
Farazi, Paraskevi A. ;
DePinho, Ronald A. .
NATURE REVIEWS CANCER, 2006, 6 (09) :674-687
[8]  
Fioretti F, 1998, J IMMUNOL, V161, P342
[9]   Impaired host defense, hematopoiesis, guanulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 [J].
Gao, JL ;
Wynn, TA ;
Chang, Y ;
Lee, EJ ;
Broxmeyer, HE ;
Cooper, S ;
Tiffany, HL ;
Westphal, H ;
KwonChung, J ;
Murphy, PM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (11) :1959-1968
[10]   Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection [J].
Gao, W ;
Topham, PS ;
King, JA ;
Smiley, ST ;
Csizmadia, V ;
Lu, B ;
Gerard, CJ ;
Hancock, WW .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :35-44